Physician profile
John A Evans
NPI 1326076233
$13,404.20
in general payments reported to CMS, 2019-2025
12 companies · $2,850 in 2025
The $2,850 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,368 · 2020: $78.18 · 2021: $508 · 2022: $4,923 · 2023: $620 · 2024: $56.40 · 2025: $2,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,109 · Food and Beverage: $1,419.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,108.73 |
| Food and Beverage | $1,418.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pentax of America, INC. | $9,496.57 | 2019-2025 | Inspira, Pentax Medical, C2 Cryoballoon |
| Boston Scientific Corporation | $2,604.86 | 2019-2025 | Orise, Exalt Model D, Spyglass |
| Medtronic, INC. | $490.94 | 2021-2023 | Gi Genius, Pillcam |
| Abiomed | $197.28 | 2020-2024 | Impella |
| Astrazeneca Pharmaceuticals Lp | $162.63 | 2025 | |
| Erbe USA INC | $150.00 | 2025 | Erbevio/Apc |
| Ambu INC. | $139.84 | 2021 | |
| Abbott Laboratories | $49.58 | 2025 | Navitor, Triclip |
| Atricure, INC. | $42.84 | 2022-2023 | |
| Apollo Endosurgery US INC | $42.49 | 2022 | |
| Ironwood Pharmaceuticals, INC | $14.08 | 2023 | Linzess |
| Kls-Martin L.P. | $13.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.